Inactive Instrument

Analyst Reco. Sinopharm Group Co., Ltd. Shanghai - Hong Kong Stock Connect

Equities

Nomura Adjusts Sinopharm Group’s Price Target to HK$32.39 Form HK$33.31, Keeps at Buy	03-11	MT
Interest Rates, Earnings, FX Roil Asian Stock Markets	11-24	MT
Nomura Adjusts Sinopharm Group's Price Target to HK$33.31 From HK$36.28, Keeps at Buy	23-10-19	MT
Nomura Adjusts Sinopharm's Price Target to HK$36.28 From HK$36.88, Keeps at Buy	23-07-27	MT
UBS Adjusts Sinopharm Group's Price Target to HK$26 From HK$28, Keeps at Buy	22-08-31	MT
UBS Adjusts Sinopharm's Price Target to HK$28 From HK$30, Keeps at Buy	22-03-25	MT
WHO sees more evidence that Omicron causes milder symptoms	22-01-04	RE
WHO sees more evidence that Omicron causes milder symptoms	22-01-04	RE
Kenya to start giving COVID-19 booster shots	21-12-25	RE
Sinovac Biotech : China considers mixing COVID-19 vaccines to boost protection rate	21-04-11	RE
Sinovac Biotech : China considering mixing COVID-19 vaccines due to low efficacy rates	21-04-11	RE

No results for this search